The Valley Desk

NCT04139304 · Interventional trial

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Overall registry status Recruiting

Early Phase 1

Conditions Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, Plasmablastic Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov